Toxicological analysis in rats subjected to heroin and morphine overdose

Toxicology Letters

Volumn 166, Issue 1, 2006, Pages 11-18

  Strandberg, Joakim J ^a   Kugelberg, Fredrik C ^a   Alkass, Kanar ^a   Gustavsson, Anna ^a   Zahlsen, Kolbjørn ^b   Spigset, Olav ^b,c   Druid, Henrik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Glucuronide; Heroin; Opiate; Overdose; Pharmacokinetics; Tolerance

Indexed keywords

DIAMORPHINE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 ACETATE;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD SAMPLING; BRAIN LEVEL; BRAIN TISSUE; CELL PROTECTION; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG OVERDOSE; LUNG PARENCHYMA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HEROIN; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LUNG; MALE; METABOLIC DETOXICATION, DRUG; MORPHINE; OVERDOSE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33747755499     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.05.007     Document Type: Article

References (25)

1. Abbott F.V., and Palmour R.M. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 43 (1988) 1685-1695
2. Aderjan R.E., and Skopp G. Formation and clearance of active and inactive metabolites of opiates in humans. Ther. Drug Monit. 20 (1998) 561-569
3. Antonilli L., Suriano C., Paolone G., Badiani A., and Nencini P. Repeated exposures to heroin and/or cadmium alter the rate of formation of morphine glucuronides in the rat. J. Pharmacol. Exp. Ther. 307 (2003) 651-660
4. Bennett G.A., and Higgins D.S. Accidental overdose among injecting drug users in Dorset, UK. Addiction 94 (1999) 1179-1189
5. Bogusz M.J., Maier R.D., Erkens M., and Driessen S. Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B: Biomed. Sci. Appl. 5 (1997) 115-127
6. Borron S.W., Monier C., Risède P., and Baud F.J. Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat. Hum. Exp. Toxicol. 21 (2002) 599-605
7. Bruce R.D. An up-and-down procedure for acute toxicity testing. Fund. Appl. Toxicol. 5 (1985) 151-157
8. Bullock P., Spanner S., and Ansell G.B. Distribution of morphine and morphine metabolites in rat brain. Biochem. Soc. Trans. 5 (1977) 166-168
9. Darke S., Ross J., Zador D., and Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend. 60 (2000) 141-150
10. Darke S., and Zador D. Fatal heroin 'overdose': a review. Addiction 91 (1996) 1765-1772
11. Dixon W.J. The up-and-down method for small samples. J. Am. Stat. Assoc. 60 (1965) 967-978
12. Druid, H., Strandberg, J.J., Alkass, K., Nystrom, I., Kugelberg, F.C., Kronstrand, R., 2006. Evaluation of the role of abstinence in heroin overdose deaths using segmental hair analysis. Forens. Sci. Int., Mar 22 [Epub ahead of print].
13. Gardmark M., Karlsson M.O., Jonsson F., and Hammarlund-Udenaes M. Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling. J. Pharm. Sci. 87 (1998) 813-820
14. Hemstapat K., Smith S.A., Monteith G.R., and Smith M.T. The neuroexcitatory morphine metabolite, morphine-3-glucuronide (M3G), is not neurotoxic in primary cultures of either hippocampal or cerebellar granule neurones. Pharmacol. Toxicol. 93 (2003) 197-200
15. Jackson H. The evaluation of analgesic potency of drugs using thermal stimulation in the rat. Br. J. Pharmacol. Chemother. 7 (1952) 196-203
16. Kamata O., Watanabe S., and Ishii S. Analgesic effect of morphine glucuronides. Proceedings of the 89th Meeting Pharmacology Society. Japan (1969) 443
17. Lötsch J. Opioid metabolites. J. Pain Symptom Manage. 29 (2005) 10-24
18. Manning F.J., Ingraham L.H., DeRouin E.M., Vaughn M.S., Kukura F.C., and St Michel G.R. Drug "overdoses" among U.S. soldiers in Europe, 1978-1979. II. autopsies following deaths and near-deaths. Int. J. Addict. 18 (1983) 153-166
19. Meissner C., Recker S., Reiter A., Friedrich H.J., and Oehmichen M. Fatal versus non-fatal heroin "overdose": blood morphine concentrations with fatal outcome in comparison to those of intoxicated drivers. Forens. Sci. Int. 130 (2002) 49-54
20. Milne R.W., Nation R.L., and Somogyi A.A. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab. Rev. 28 (1996) 345-472
21. Nakamura G.R. Toxicologic assessments in acute heroin fatalities. Clin. Toxicol. 13 (1978) 75-87
22. Shimomura K., Kamata O., Ueki S., Ida S., and Oguri K. Analgesic effect of morphine glucuronides. Tohoku J. Exp. Med. 105 (1971) 45-52
23. Siegel S., Hinson R.E., Krank M.D., and McCully J. Heroin "overdose" death: contribution of drug-associated environmental cues. Science 216 (1982) 436-437
24. Sullivan A.F., McQuay H.J., Bailey D., and Dickenson A.H. The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat. Brain Res. 482 (1989) 219-224
25. White J.M., and Irvine R.J. Mechanisms of fatal opioid overdose. Addiction 94 (1999) 961-972